Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 60

1.

Species-specific susceptibility to cannabis-induced convulsions.

Whalley BJ, Lin H, Bell L, Hill T, Patel A, Gray RA, Elizabeth Roberts C, Devinsky O, Bazelot M, Williams CM, Stephens GJ.

Br J Pharmacol. 2018 Feb 19. doi: 10.1111/bph.14165. [Epub ahead of print]

PMID:
29457829
2.

mTOR-related neuropathology in mutant tsc2 zebrafish: Phenotypic, transcriptomic and pharmacological analysis.

Scheldeman C, Mills JD, Siekierska A, Serra I, Copmans D, Iyer AM, Whalley BJ, Maes J, Jansen AC, Lagae L, Aronica E, de Witte PAM.

Neurobiol Dis. 2017 Dec;108:225-237. doi: 10.1016/j.nbd.2017.09.004. Epub 2017 Sep 6.

PMID:
28888969
3.

Sonic hedgehog signalling mediates astrocyte crosstalk with neurons to confer neuroprotection.

Ugbode CI, Smith I, Whalley BJ, Hirst WD, Rattray M.

J Neurochem. 2017 Aug;142(3):429-443. doi: 10.1111/jnc.14064. Epub 2017 Jun 20.

4.

Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.

Rosenberg EC, Patra PH, Whalley BJ.

Epilepsy Behav. 2017 May;70(Pt B):319-327. doi: 10.1016/j.yebeh.2016.11.006. Epub 2017 Feb 9. Review.

5.

Evaluation of Possible Consequences of Zika Virus Infection in the Developing Nervous System.

Walter LT, Higa GSV, Ikebara JM, Vedovello D, Salvador FS, Takada SH, Kinjo ER, Whalley BJ, Sperança MA, Kihara AH.

Mol Neurobiol. 2018 Feb;55(2):1620-1629. doi: 10.1007/s12035-017-0442-5. Epub 2017 Feb 11. Review.

PMID:
28190239
6.

A cannabigerol-rich Cannabis sativa extract, devoid of [INCREMENT]9-tetrahydrocannabinol, elicits hyperphagia in rats.

Brierley DI, Samuels J, Duncan M, Whalley BJ, Williams CM.

Behav Pharmacol. 2017 Jun;28(4):280-284. doi: 10.1097/FBP.0000000000000285.

PMID:
28125508
7.

Molecular Pharmacology of Phytocannabinoids.

Turner SE, Williams CM, Iversen L, Whalley BJ.

Prog Chem Org Nat Prod. 2017;103:61-101. doi: 10.1007/978-3-319-45541-9_3. Review.

PMID:
28120231
8.

Characterisation of Development and Electrophysiological Mechanisms Underlying Rhythmicity of the Avian Lymph Heart.

Jaffer S, Valasek P, Luke G, Batarfi M, Whalley BJ, Patel K.

PLoS One. 2016 Dec 8;11(12):e0166428. doi: 10.1371/journal.pone.0166428. eCollection 2016.

9.

The cannabinoid CB2 receptor-specific agonist AM1241 increases pentylenetetrazole-induced seizure severity in Wistar rats.

de Carvalho CR, Hoeller AA, Franco PL, Martini AP, Soares FM, Lin K, Prediger RD, Whalley BJ, Walz R.

Epilepsy Res. 2016 Nov;127:160-167. doi: 10.1016/j.eplepsyres.2016.08.011. Epub 2016 Aug 29.

PMID:
27608434
10.

Cannabinoid type 1 receptor antagonism ameliorates harmaline-induced essential tremor in rat.

Abbassian H, Whalley BJ, Sheibani V, Shabani M.

Br J Pharmacol. 2016 Nov;173(22):3196-3207. doi: 10.1111/bph.13581. Epub 2016 Oct 4.

11.

The neurogenesis of P1 and N1: A concurrent EEG/LFP study.

Bruyns-Haylett M, Luo J, Kennerley AJ, Harris S, Boorman L, Milne E, Vautrelle N, Hayashi Y, Whalley BJ, Jones M, Berwick J, Riera J, Zheng Y.

Neuroimage. 2017 Feb 1;146:575-588. doi: 10.1016/j.neuroimage.2016.09.034. Epub 2016 Sep 16.

12.

Cannabigerol is a novel, well-tolerated appetite stimulant in pre-satiated rats.

Brierley DI, Samuels J, Duncan M, Whalley BJ, Williams CM.

Psychopharmacology (Berl). 2016 Oct;233(19-20):3603-13. doi: 10.1007/s00213-016-4397-4. Epub 2016 Aug 9.

13.

Cannabinoid receptor agonism suppresses tremor, cognition disturbances and anxiety-like behaviors in a rat model of essential tremor.

Abbassian H, Esmaeili P, Tahamtan M, Aghaei I, Vaziri Z, Sheibani V, Whalley BJ, Shabani M.

Physiol Behav. 2016 Oct 1;164(Pt A):314-20. doi: 10.1016/j.physbeh.2016.06.013. Epub 2016 Jun 15.

PMID:
27317835
14.

A Low Mortality, High Morbidity Reduced Intensity Status Epilepticus (RISE) Model of Epilepsy and Epileptogenesis in the Rat.

Modebadze T, Morgan NH, Pérès IA, Hadid RD, Amada N, Hill C, Williams C, Stanford IM, Morris CM, Jones RS, Whalley BJ, Woodhall GL.

PLoS One. 2016 Feb 24;11(2):e0147265. doi: 10.1371/journal.pone.0147265. eCollection 2016.

15.

Nuclear accumulation of myocyte muscle LIM protein is regulated by heme oxygenase 1 and correlates with cardiac function in the transition to failure.

Paudyal A, Dewan S, Ikie C, Whalley BJ, de Tombe PP, Boateng SY.

J Physiol. 2016 Jun 15;594(12):3287-305. doi: 10.1113/JP271809. Epub 2016 May 5.

16.

Neuronal-glial populations form functional networks in a biocompatible 3D scaffold.

Smith I, Haag M, Ugbode C, Tams D, Rattray M, Przyborski S, Bithell A, Whalley BJ.

Neurosci Lett. 2015 Nov 16;609:198-202. doi: 10.1016/j.neulet.2015.10.044. Epub 2015 Oct 19.

PMID:
26493605
17.

Neuromotor tolerability and behavioural characterisation of cannabidiolic acid, a phytocannabinoid with therapeutic potential for anticipatory nausea.

Brierley DI, Samuels J, Duncan M, Whalley BJ, Williams CM.

Psychopharmacology (Berl). 2016 Jan;233(2):243-54. doi: 10.1007/s00213-015-4100-1. Epub 2015 Oct 6.

PMID:
26439367
18.

Erratum to: Cannabinoids in the Treatment of Neurological Disorders.

Devinsky O, Whalley BJ, Di Marzo V.

Neurotherapeutics. 2015 Oct;12(4):910. doi: 10.1007/s13311-015-0392-4. No abstract available.

19.

Cannabinoids in the Treatment of Neurological Disorders.

Devinsky O, Whalley BJ, Di Marzo V.

Neurotherapeutics. 2015 Oct;12(4):689-91. doi: 10.1007/s13311-015-0388-0. No abstract available. Erratum in: Neurotherapeutics. 2015 Oct;12(4):910.

20.

Cannabinoids and Epilepsy.

Rosenberg EC, Tsien RW, Whalley BJ, Devinsky O.

Neurotherapeutics. 2015 Oct;12(4):747-68. doi: 10.1007/s13311-015-0375-5. Review.

Supplemental Content

Loading ...
Support Center